ORGANON CANADA ANNOUNCES THE APPROVAL AND AVAILABILITY OF NDUVRA® (TAPINAROF CREAM), 1%, A NEW STEROID-FREE TOPICAL TREATMENT FOR MODERATE TO SEVERE ATOPIC DERMATITIS IN ADULT AND PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER

Reuters · 2d ago

Please log in to view news